Community/Retail

The emergence of a new Medicare Advantage plan, Troy Medicare, offers much needed momentum to drive pharmacists’ services.

The researchers found that the likelihood of being hospitalized for a somatic disease was just as high during the periods when the patients were on antipsychotic drugs as when they were not; however, the differences in mortality were clear.

Upsher-Smith has launched fluvoxamine maleate tablets in 25 mg, 50 mg, and 100 mg strengths.

Lower-priced versions of Humalog Mix75/25 KwikPen and Humalog Junior KwikPen will be available in mid-April and will have 50% lower list prices compared with branded versions.

Influenza B has been causing severe illnesses in many areas of the country.

The proposal, which is still largely conceptual, was a part of Newsom’s proposed 2020-2021 budget.1

Sunday was National Pharmacist Day, and we asked on Facebook why you entered the pharmacy field, and why you continue to believe in the importance of the profession.

A new study published in The American Journal of Emergency Medicine found that rapid correction of elevated serum potassium levels was associated with significant reduced mortality in patients admitted to the emergency department (ED) for hyperkalemia.

Independent pharmacists have noted a growing trend in which Amazon’s Pillpack is sending unsolicited phone calls to their patients as a way of requesting transfers of prescriptions.

Why does a patient's levothyroxine dose need to be adjusted?

Upsher-Smith Laboratories have launched haloperidol tablets, USP the generic version of the brand product, Haldol Tablets.

A key demand was for the Ohio Department of Medicaid (ODM) to set a minimum reimbursement level and dispensing fees for Managed Medicaid, in order to ensure that pharmacies receive adequate reimbursement plans.

Hemophagocytic lymphohistiocytosis (HLH) induced by lamotrigine was recently an active topic on social media, with users following a recent article that reported an Austin, Texas detective had died from the condition in 2018.

Micafungin injection is the first antifungal drug approved in the United States specifically for pediatric patients younger than 4 years of age with invasive candidiasis.

Study seeks to determine how HIV avoids the zinc-finger antiviral protein and how it binds the RNA.

There are some basic tips or tricks to getting the most out of your insurance plan and to maintain the care patients are accustomed to.

The CDC has reported 34800 new cancer diagnoses linked to HPV annually, and the virus is predicted to account for more than 90% of all cervical and anal cancers, more than 60% of all penile cancers, and 70% of all oral cancers.

Members of the former International Academy of Compounding Pharmacists voted in November 2019 to change the association’s name to the Alliance for Pharmacy Compounding.

The Prescription Drug User Fee Act date, the FDA action data for this supplemental application, is scheduled for the second quarter of 2020.

Annoying work habits can set the tone for lower productivity and teamwork in the pharmacy.

The treatment is the first and only fast-acting mealtime insulin injection that does not have a pre-meal dosing recommendation, according to Novo Nordisk.

Could tadalafil be causing a patient to feel dizzy?

At the recent ASHP (American Society of Health-System Pharmacists) Midyear Clinical Meeting & Exhibition in Las Vegas, Nevada, 3 speakers discussed new developments in influenza management.

The bill would have given the state's superintendent of insurance licensing and regulatory authority over pharmacy benefit managers (PBMs).1

Novadoz Pharmaceuticals, who markets the product, has commenced shipping of the drug, available in bottles of 30 tablets.

From newsworthy moments to groundbreaking research, these are the most popular articles published on Pharmacy Times® during 2019.

Officials with the FDA have approved Eisai’s lemborexant (Dayvigo) 5 mg and 10 mg for the treatment of adult patients with insomnia, characterized by difficulties with sleep onset and/or sleep maintenance.

Officials with the FDA have approved Intra-Cellular Therapies’ lumateperone (Caplyta) for the treatment of schizophrenia in adults, according to the company.